|
US4487934A
(en)
|
1980-06-06 |
1984-12-11 |
Hoechst-Roussel Pharmaceuticals Inc. |
Method of preparing poly-substituted acylbenzenes
|
|
US4501729A
(en)
*
|
1982-12-13 |
1985-02-26 |
Research Corporation |
Aerosolized amiloride treatment of retained pulmonary secretions
|
|
DE3326472A1
(de)
|
1983-07-22 |
1985-02-14 |
Hoechst Ag, 6230 Frankfurt |
Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
|
|
ATE35810T1
(de)
|
1984-04-06 |
1988-08-15 |
Zambon Spa |
Verfahren zur herstellung von optisch aktiven alpha-arylalkansaeuren und ihre zwischenprodukte.
|
|
JP3481236B2
(ja)
*
|
1990-10-05 |
2003-12-22 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
固体粒状薬剤及び固体粒状薬剤エーロゾル投薬装置
|
|
US5173414A
(en)
*
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
US5292498A
(en)
*
|
1991-06-19 |
1994-03-08 |
The University Of North Carolina At Chapel Hill |
Method of treating lung disease with uridine triphosphates
|
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
|
US5686436A
(en)
|
1993-05-13 |
1997-11-11 |
Hiv Diagnostics, Inc. |
Multi-faceted method to repress reproduction of latent viruses in humans and animals
|
|
US5512269A
(en)
*
|
1993-06-09 |
1996-04-30 |
Burroughs Wellcome, Co. |
Method of treating retained pulmonary secretions
|
|
US5498531A
(en)
|
1993-09-10 |
1996-03-12 |
President And Fellows Of Harvard College |
Intron-mediated recombinant techniques and reagents
|
|
US5750398A
(en)
*
|
1993-11-30 |
1998-05-12 |
David C. Johnson |
Vector, element and method for inhibiting immune recognition
|
|
US5604090A
(en)
*
|
1994-06-06 |
1997-02-18 |
Fred Hutchinson Cancer Research Center |
Method for increasing transduction of cells by adeno-associated virus vectors
|
|
US5656256A
(en)
*
|
1994-12-14 |
1997-08-12 |
The University Of North Carolina At Chapel Hill |
Methods of treating lung disease by an aerosol containing benzamil or phenamil
|
|
US5843742A
(en)
*
|
1994-12-16 |
1998-12-01 |
Avigen Incorporated |
Adeno-associated derived vector systems for gene delivery and integration into target cells
|
|
US6281010B1
(en)
*
|
1995-06-05 |
2001-08-28 |
The Trustees Of The University Of Pennsylvania |
Adenovirus gene therapy vehicle and cell line
|
|
US5635160A
(en)
*
|
1995-06-07 |
1997-06-03 |
The University Of North Carolina At Chapel Hill |
Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
|
|
US5628984A
(en)
*
|
1995-07-31 |
1997-05-13 |
University Of North Carolina At Chapel Hill |
Method of detecting lung disease
|
|
EP0863913A4
(en)
*
|
1995-08-21 |
2001-04-11 |
Univ Duke |
METHOD FOR RECOVERING THE DENSITY OF ANTIGENS ON ANTIGENT PRESENTING CELLS
|
|
US5801030A
(en)
*
|
1995-09-01 |
1998-09-01 |
Genvec, Inc. |
Methods and vectors for site-specific recombination
|
|
WO1997009997A1
(en)
*
|
1995-09-12 |
1997-03-20 |
Genentech, Inc. |
Cystic fibrosis therapy
|
|
US6083702A
(en)
*
|
1995-12-15 |
2000-07-04 |
Intronn Holdings Llc |
Methods and compositions for use in spliceosome mediated RNA trans-splicing
|
|
EP0883344B2
(en)
|
1995-12-15 |
2010-06-09 |
VIRxSYS Corporation |
Therapeutic molecules generated by trans-splicing
|
|
US6420347B1
(en)
*
|
1997-03-27 |
2002-07-16 |
Inspire Pharmaceuticals, Inc. |
Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
|
|
EP1696036B1
(en)
|
1996-09-06 |
2010-04-21 |
The Trustees of The University of Pennsylvania |
Use of recombinant adeno-associated virus in the manufacture of a medicament for gene therapy via muscle cells
|
|
WO1998024479A1
(en)
|
1996-12-02 |
1998-06-11 |
Cell Genesys, Inc. |
Adeno-associated viral vector-mediated delivery of dna to cells of the liver
|
|
US6287569B1
(en)
*
|
1997-04-10 |
2001-09-11 |
The Regents Of The University Of California |
Vaccines with enhanced intracellular processing
|
|
FR2763845B1
(fr)
|
1997-05-30 |
2003-04-18 |
Centre Nat Rech Scient |
Produits anti-cancereux pour le traitement de la mucoviscidose
|
|
US6156303A
(en)
*
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
US6037177A
(en)
|
1997-08-08 |
2000-03-14 |
Cell Genesys, Inc. |
Method for increasing the efficiency of recombinant AAV production
|
|
BR9811612A
(pt)
*
|
1997-08-29 |
2000-08-08 |
Univ North Carolina |
Uso de 5' -difosfato de uridina e similares para tratamento de doenças pulmonares
|
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
|
DE69905464T2
(de)
*
|
1998-05-22 |
2004-01-15 |
Inspire Pharmaceuticals Inc |
Therapeutische dinucleotide und deren derivate
|
|
US6290951B1
(en)
*
|
1998-08-01 |
2001-09-18 |
Alfacell Corporation |
Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells
|
|
US6221349B1
(en)
*
|
1998-10-20 |
2001-04-24 |
Avigen, Inc. |
Adeno-associated vectors for expression of factor VIII by target cells
|
|
US6264975B1
(en)
*
|
1998-10-20 |
2001-07-24 |
The University Of North Carolina At Chapel Hill |
Methods of hydrating mucosal surfaces
|
|
US6200560B1
(en)
*
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
|
US6855549B1
(en)
*
|
1998-11-23 |
2005-02-15 |
The University Of Iowa Research Foundation |
Methods and compositions for increasing the infectivity of gene transfer vectors
|
|
US6926911B1
(en)
*
|
1998-12-22 |
2005-08-09 |
The University Of North Carolina At Chapel Hill |
Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
|
|
EP1153612A4
(en)
|
1999-02-10 |
2003-06-18 |
Takashi Tsuruo |
Anticancer agent potentiators
|
|
US6306663B1
(en)
*
|
1999-02-12 |
2001-10-23 |
Proteinex, Inc. |
Controlling protein levels in eucaryotic organisms
|
|
JP4969002B2
(ja)
|
1999-06-08 |
2012-07-04 |
ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン |
ｒＡＡＶ形質導入を増加するための化合物および方法
|
|
US7122335B1
(en)
*
|
1999-06-08 |
2006-10-17 |
University Of Iowa Research Foundation |
Compounds and methods to enhance rAAV transduction
|
|
ATE390414T1
(de)
*
|
1999-07-19 |
2008-04-15 |
Univ North Carolina |
Arzneimittelwirkstoffe mit zwei kovalent verknüpften wirkstoffgruppen (natriumkanalblocker/p2y2 rezeptor agonist) zur behandlung von schleimhäuten
|
|
US6475537B1
(en)
*
|
2000-07-27 |
2002-11-05 |
Rhodia Inc. |
Hops acid antibacterial compositions
|
|
US6416759B1
(en)
*
|
1999-09-30 |
2002-07-09 |
The Regents Of The University Of California |
Antiproliferative Sgk reagents and methods
|
|
EP1224313A1
(en)
|
1999-10-07 |
2002-07-24 |
University of Iowa Research Foundation |
Adeno-associated viruses and uses thereof
|
|
JP2003511082A
(ja)
*
|
1999-10-12 |
2003-03-25 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
第ｖｉｉｉ因子をコードするアデノ随伴ウィルスベクターとその使用法
|
|
US6544786B1
(en)
*
|
1999-10-15 |
2003-04-08 |
University Of Pittsburgh Of The Commonwealth Of Higher Education |
Method and vector for producing and transferring trans-spliced peptides
|
|
US20020132770A1
(en)
*
|
1999-10-27 |
2002-09-19 |
Caplan Michael T. |
Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
|
|
WO2001066782A1
(en)
*
|
2000-03-03 |
2001-09-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Adeno-associated viral compositions and methods
|
|
CA2302627A1
(en)
|
2000-03-23 |
2001-09-23 |
Rashmi Kothary |
Constructs comprising the enac promoter sequence and a reporter gene for screening pharmaceuticals
|
|
US20020076754A1
(en)
*
|
2000-04-20 |
2002-06-20 |
Liangwu Sun |
Overcoming AAV vector size limitation through viral DNA hetero-dimerization
|
|
JP2004514407A
(ja)
|
2000-04-28 |
2004-05-20 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
異種キャプシド中にシュードタイピングされたａａｖ５キャプシドおよびａａｖ５ベクターを含む組換えａａｖベクター
|
|
US20020128203A1
(en)
|
2000-09-20 |
2002-09-12 |
Laurent Schild |
Methods of identifying inhibitory compounds and uses thereof
|
|
ES2225600T3
(es)
|
2000-09-22 |
2005-03-16 |
Galephar M/F |
Composicion semi-solida de isotretinoina.
|
|
WO2002028348A2
(en)
*
|
2000-10-04 |
2002-04-11 |
The Children's Hospital Of Philadelphia |
Compositions and methods for treatment of cystic fibrosis
|
|
US20030087818A1
(en)
*
|
2001-02-02 |
2003-05-08 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
|
US20030013137A1
(en)
|
2001-03-13 |
2003-01-16 |
Barak Larry S. |
Automated methods of detecting receptor activity
|
|
US6586416B2
(en)
*
|
2001-04-19 |
2003-07-01 |
James K. Bubien |
Methods of treatment using an epithelial sodium channel blocker and an inhibitor of the mineralocorticoid receptor
|
|
WO2002087306A2
(en)
|
2001-05-01 |
2002-11-07 |
Senomyx, Inc. |
High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds
|
|
US20030003583A1
(en)
*
|
2001-06-08 |
2003-01-02 |
Raphael Hirsch |
Regulation of transgene expression following AAV transduction
|
|
US8241622B2
(en)
*
|
2001-07-13 |
2012-08-14 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences
|
|
CA2453405A1
(en)
*
|
2001-07-13 |
2003-01-23 |
University Of Iowa Research Foundation |
Pseudotyped adeno-associated viruses and uses thereof
|
|
EP1478655A4
(en)
|
2001-12-31 |
2006-05-10 |
Algos Therapeutics Inc |
METHODS AND SUBSTANCES FOR ENAC-BETA MODULATION
|
|
SI1509618T1
(sl)
|
2002-05-13 |
2009-02-28 |
Arexis Ab |
Avtoimunska stanja in defekti NADPH oksidaze
|
|
WO2004089423A2
(en)
*
|
2003-03-31 |
2004-10-21 |
University Of Iowa Research Foundation |
Pharmico-gene theraphy of epithelial sodium channel associated disoders
|
|
EP1486567A1
(en)
|
2003-06-11 |
2004-12-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Improved adeno-associated virus (AAV) vector for gene therapy
|
|
PL2657248T3
(pl)
|
2003-06-19 |
2017-09-29 |
Genzyme Corporation |
Wiriony AAV o zmniejszonej immunoreaktywności i ich zastosowanie
|
|
WO2005049850A2
(en)
|
2003-11-14 |
2005-06-02 |
University Of Washington |
Compositions and methods for systemic nucleic acid sequence delivery
|
|
WO2005116224A2
(en)
|
2004-05-18 |
2005-12-08 |
Children's Memorial Hospital |
Tetracycline-regulated adeno-associated viral (aav) vectors for gene delivery to the nervous system
|
|
EP1602926A1
(en)
|
2004-06-04 |
2005-12-07 |
University of Geneva |
Novel means and methods for the treatment of hearing loss and phantom hearing
|
|
EP2019964A2
(en)
|
2006-04-28 |
2009-02-04 |
University of Iowa Research Foundation |
Methods and compounds to modulate parvovirus transduction of mammalian cells or to alter virus infection. method to identify a viral receptor or co-receptor
|
|
EP2184073A4
(en)
*
|
2007-08-24 |
2010-10-20 |
Kyowa Hakko Kirin Co Ltd |
AGAINST PROTEASE HEMMER RESISTANT CANCER THERAPEUTICS
|